Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MCKESSON CORPORATION

(MCK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

McKesson : Goldman Sachs Adjusts Price Target on McKesson to $257 From $231, Maintains Buy Rating

05/07/2021 | 11:58am EDT


© MT Newswires 2021
All news about MCKESSON CORPORATION
06/11MCKESSON  : LUMAKRAS (sotorasib), FDA Approved for Treatment of KRAS G12C-mutate..
PU
06/08MCKESSON  : 2021 Annual Meeting of Shareholders and Proxy Statement
PU
06/08MCKESSON  : 2021 Annual Report
PU
06/08Amazon Pharmacy offers half-yearly prescriptions starting at $6
RE
06/07CORRECTION : Mizuho Securities Maintains Price Target for McKesson at $205, Reit..
MT
06/07MCKESSON  : Mizuho Securities Adjusts McKesson PT to $190 From $205, Maintains N..
MT
06/03MCKESSON  : Insider Sale at McKesson (MCK) Continues Selling Trend
MT
06/03MCKESSON  : US Oncology Research, The US Oncology Network and Ontada Announce Cl..
PU
06/02INSIDER TRENDS : Insider at McKesson Converts/Exercises Derivative Security, Sel..
MT
06/02INSIDER TRENDS : Insider at McKesson Acquires Stock Via Option/Derivative Securi..
MT
More news
Financials (USD)
Sales 2022 249 B - -
Net income 2022 2 717 M - -
Net Debt 2022 539 M - -
P/E ratio 2022 11,1x
Yield 2022 0,91%
Capitalization 30 237 M 30 237 M -
EV / Sales 2022 0,12x
EV / Sales 2023 0,11x
Nbr of Employees 67 500
Free-Float 56,6%
Chart MCKESSON CORPORATION
Duration : Period :
McKesson Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MCKESSON CORPORATION
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 224,31 $
Last Close Price 193,01 $
Spread / Highest target 33,2%
Spread / Average Target 16,2%
Spread / Lowest Target 2,59%
EPS Revisions
Managers and Directors
NameTitle
Brian Scott Tyler Chief Executive Officer & Director
Britt J. Vitalone Chief Financial Officer & Executive Vice President
Edward A. Mueller Chairman
Nancy Flores EVP, Chief Technology & Information Officer
M. Christine Jacobs Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MCKESSON CORPORATION12.41%30 237
WALGREENS BOOTS ALLIANCE, INC.38.69%47 810
JD HEALTH INTERNATIONAL INC.-27.87%44 398
CARDINAL HEALTH, INC.10.74%17 209
HUADONG MEDICINE CO., LTD80.27%13 094
SINOPHARM GROUP CO., LTD.37.86%10 455